Tag: ASTI

Blue Horseshoe Stocks: TSLA Options Recap & More

Tesla Motors, Inc. TSLA – Options

Despite another choppy day for the markets as a whole, we were able to find a diamond in the rough with our TSLA Options Idea in Thursday’s premarket report.

As the stock was gapping up, we identified the possibility of some dip-and-rip scenarios occurring in weekly TSLA $275-280 Calls and that’s precisely what we got. There was some extremely impressive action with the $275’s and $277.50’s in particular, that could’ve provided traders with exponential gains.

The $275 Calls jumped out of the starting gate and went on an initial run from 5.00 to 7.60 (+52%) in the first couple minutes of the session. The dip-and-rip we were after provided an even bigger opportunity as the contracts reached a midday low of .78 before rebounding, and absolutely exploded back to a 5.10 close. That marked a second intraday rip of 554%

The $277.50’s traded in a similar pattern; the initial move was from 3.20 to 5.40 (+69%), and their dip took them to a low of .21 before re-launching as high as 3.00 into the close. That was a mind-boggling 1329% rip.

NuGene International, Inc. NUGN

NUGN has been an ongoing point of interest for us over the past few weeks; we alerted the stock in the third week of June, and at that time, observed a 2.67 swing-low. Since then, the chart has been on a steady incline, surging as much as 47% as it hit a high of 3.88 on both Wednesday and Thursday.

We’ll be looking for the possibility of the stock cracking through that resistance to continue its uptrend into this week.

There’s a fresh PR coming off of the wire this morning as well:

IRVINE, Calif., July 6, 2015 /PRNewswire/ — NuGene International, Inc. (“NuGene”) (NUGN), a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, conducted one-on-one meetings with top beauty editors in New York City including Allure, Vogue, Glamour, Marie Claire, Self, Shape, More, Town and Country, People, People Style Watch, Cosmopolitan, Better Homes and Gardens and W. >> View PR

Extended Watchlist:
PVSP, WTW, ONCY, JDST, CLSN, ASTI, ENZN

Blue Horseshoe Stocks: MDCN Recap, Options Idea & More

Medican Enterprises, Inc. MDCN

In yesterday morning’s premarket report we took note of MDCN’s rebound off of a relative bottom, and speculated that the momentum built up in Tuesday’s session could carry over into added gains.

That certainly proved to be the case, as MDCN spiked heavily from its early low of .0024, running as high as .0039 shortly before 11:30AM. It marked an intraday move which provided gain opportunities of up to 62% before pulling back into the close of .0022.

We’ll go ahead and monitor this one for the remainder of the week for any potential bounce-play chances that might arise when it finds solid support. We’ll look for that to occur at or above Tuesday’s low of .0015.

Isis Pharmaceuticals, Inc. ISIS – Options Idea

ISIS appears to be in full-on breakout mode this morning, and as a result we thought we’d formulate an idea to take advantage of this via the options chain.

Given the current price and conditions caused by this morning’s catalyst (link to PR below), we’re going to be tracking the activity in the Weekly $70-73 Calls for potential intraday flip opportunities.

Extended Watchlist:
PTBI, RAD, SFUN, ATOS, AGEN, ASTI

Blue Horseshoe Stocks: New Options Idea & More

Vivint Solar, Inc. VSLR – Options Idea

VSLR caught our eye yesterday as the stock made considerable progress in coming off of a recent bottom, aided by Q4 financials announced Wednesday, post-market which came in better-than-expected.

In the midst of this rebound, we’ll be looking to possibly take advantage via the options chain. Currently, we’re interested in following the activity on the April 17th $11 Calls (Last Trade:1.30).

VSLR has a 1-year analyst estimated price target of 19.80, and is presently trading well below that range, thus it could turn out to be a stock that we continue to track over an extended period of time.

AVEO Pharmaceuticals, Inc. AVEO

We’re watching AVEO this morning; the stock broke above its 200DMA earlier this week and has been holding support above that level. Yesterday it underwent a gap-and-fade, ultimately finding support at 1.36. and that’s the level we’ll want to see it maintain on any further pullbacks today.

The main thing drawing our attention toward AVEO is the current chart setup.As you can see on the snapshot below, it is showing a strong RSI, a bullish MACD, and appears to be building toward an elusive Golden Cross; a relatively rare event for which we’re always keeping our eyes peeled.

Extended Watchlist:
ASTI, JDST, CRMD, MSO, AXN, GALE